URMC-099
URMC-099 is an orally bioavailable and potent mixed lineage kinase type 3 (MLK3) (IC50=14 nM) inhibitor with with excellent blood-brain barrier penetration properties.
Product Specifications
CAS Number
1229582-33-5
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Autophagy; Mixed Lineage Kinase
Type
Reference compound
Related Pathways
Autophagy; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Neurological Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/URMC-099.html
Concentration
10mM
Purity
98.69
Solubility
DMSO : ≥ 33 mg/mL
Smiles
CN(CC1)CCN1CC(C=C2)=CC=C2C3=CN=C4C(C(C5=CC=C(NC=C6)C6=C5)=CN4)=C3
Molecular Formula
C27H27N5
Molecular Weight
421.54
Precautions
H302, H315, H319, H335
References & Citations
[1]Goodfellow VS, et al. Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3. J Med Chem. 2013 Oct 24;56 (20) :8032-48.|[2]Rhoo KH, et al. Pharmacologic inhibition of MLK3 kinase activity blocks the in vitro migratory capacity of breast cancer cells but has no effect on breast cancer brain metastasis in a mouse xenograft model. PLoS One. 2014 Sep 29;9 (9) :e108487.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
172082-AF-FITC 100 µL
Cytokeratin, Basic (KRT, Type II, HMW) (FITC)
Sign In for Pricing
View Details 
